Article Details
Retrieved on: 2024-09-27 22:07:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
3. Results demonstrate the use of talquetamab as a combination agent with monoclonal antibodies. Patients' ORR was 81.8%, an improvement from the ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here